As of Feb 17
| +0.04 / +0.24%|
The 6 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 18.00, with a high estimate of 20.00 and a low estimate of 17.00. The median estimate represents a +8.89% increase from the last price of 16.53.
The current consensus among 7 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since February, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.